Medication Prescribing

Three applications for the first generic capsules have been granted by the US Food and Drug Administration.

Three applications for the first generic capsules have been granted by the US Food and Drug Administration.

This approval comes after the drug was found to be safe and effective in 2 randomized, double-blind, placebo-controlled trials including 655 adults with partial-onset seizures.

This approval comes after the drug was found to be safe and effective in 2 randomized, double-blind, placebo-controlled trials including 655 adults with partial-onset seizures.

This approval comes after the drug was found to be safe and effective in 2 randomized, double-blind, placebo-controlled trials including 655 adults with partial-onset seizures.

In a unanimous vote, the US FDA’s Endocrinologic and Metabolic Drugs Advisory Committee recommended the approval of a new indication for a triglyceride-lowering drug.

The new antibacterial drug was approved after it was proven safe and effective in a study of 448 patients with complicated UTIs.

The new antibacterial drug was approved after it was proven safe and effective in a study of 448 patients with complicated UTIs.

The new antibacterial drug was approved after it was proven safe and effective in a study of 448 patients with complicated UTIs.

After performance data showed 95% sensitivity and specificity, the FDA authorized the assay’s marketing in the United States for detection of HIV-1 drug-resistant mutations.